period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.95,0.25,0.0,0.20833333333333334,[1],The FDA is aware of emerging supply concerns in the market and is actively monitoring the situation. We encourage manufacturers and stakeholders to report any significant changes in supply levels. Coordination efforts are ongoing to ensure continued market stability.
1,1.2,0.95,0.25,0.0,0.20833333333333334,[],The FDA is aware of emerging supply challenges and is closely monitoring the situation. We encourage manufacturers and healthcare providers to report any supply issues to facilitate timely coordination.
2,1.2,0.9,0.29999999999999993,0.0,0.24999999999999994,[2],The FDA is aware of an emerging drug shortage. We encourage manufacturers to increase production and report supply levels. Buyers are advised to maintain normal purchasing patterns to avoid exacerbating the situation. Coordination among stakeholders is encouraged to ensure patient needs are met.
3,1.3,1.0225,0.2775000000000001,0.022499999999999964,0.2134615384615385,"[2, 3]",The FDA is closely monitoring the emerging drug shortage situation. We encourage manufacturers and healthcare providers to report supply issues and coordinate efforts to ensure patient needs are met.
